Johns Hopkins Outpatient Center
Baltimore, Maryland, 21287, United States
NCT Number: NCT00328315
The goal is to conduct a clinical pilot study to evaluate the use of a rotating multi-segment slant-hole collimator in the detection of myocardial defects.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Baltimore, Maryland, 21287, United States
Myocardial perfusion SPECT is recognized as an effective clinical diagnostic imaging technique in the assessment of myocardial perfusion and coronary artery diseases. It is the most important clinical application of SPECT imaging techniques.
The goal is to conduct a clinical pilot study to evaluate the use of rotating multi-segment slant-hole (RMSSH) SPECT in the detection of myocardial defects especially in very sick patients in the nuclear medicine clinics, emergence room, and intensive care units. Comparison of the clinical utilities of the cardiac RMSSH SPECT technique with conventional cardiac planar and SPECT with parallel-hole collimation will also allow us to evaluate the potential application of the technique to a wider patient population.
The objective of this study is to test the hypothesis that quantitative 99mTc myocardial perfusion RMSSH SPECT provides similar diagnostic accuracy in patients with cardiac diseases as conventional SPECT imaging techniques.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Johns Hopkins University
Other
Myocardial Perfusion SPECT Using a Rotating Multi-segment Slant-hole Collimator
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05853250
Arterial Occlusive Diseases, Arteriosclerosis
Cleveland, Ohio, United States
View Trial DetailsNCT06716255
Arterial Occlusive Diseases, Arteriosclerosis
Moscow, Russia
View Trial DetailsNCT02813473
Arterial Occlusive Diseases, Arteriosclerosis
Brussels, Belgium
View Trial DetailsNCT00920283
Arterial Occlusive Diseases, Arteriosclerosis
Cotignola, Ravenna, Italy
View Trial Details